Compare YDES & OPTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YDES | OPTU |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Cable & Other Pay Television Services |
| Sector | | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 422.9M | 411.9M |
| IPO Year | 2024 | 2017 |
| Metric | YDES | OPTU |
|---|---|---|
| Price | $5.51 | $0.63 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $1.08 |
| AVG Volume (30 Days) | 99.8K | ★ 4.0M |
| Earning Date | 08-31-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,590,467,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.70 | $0.48 |
| 52 Week High | $15.72 | $2.14 |
| Indicator | YDES | OPTU |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 42.11 |
| Support Level | $4.69 | $0.54 |
| Resistance Level | $8.60 | $0.91 |
| Average True Range (ATR) | 0.81 | 0.11 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 21.92 | 29.89 |
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Optimum's assets were brought together when Altice Europe acquired US cable companies Suddenlink in 2015 and Cablevision in 2016. The Suddenlink business, which management calls the "West," provides television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. The Cablevision portion, dubbed the "East," provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Optimum, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018.